Your browser doesn't support javascript.
loading
Differences in intensity and quality of bowel symptoms in patients with colorectal endometriosis : An observational cross-sectional study.
Reh, Lena Maria; Darici, Ezgi; Montanari, Eliana; Keckstein, Joerg; Senft, Birgit; Dauser, Bernhard; Hudelist, Gernot.
Affiliation
  • Reh LM; Department of Gynecology, Center for Endometriosis, Hospital St. John of God, Vienna, Austria.
  • Darici E; Brussels IVF, Centre for Reproductive Medicine Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Av. du Laerbeek 101, 1090, Jette, Belgium. ezgidarici@hotmail.com.
  • Montanari E; Department of Gynecology, Center for Endometriosis, Hospital St. John of God, Vienna, Austria.
  • Keckstein J; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
  • Senft B; Practice Drs. Keckstein, Villach, Austria.
  • Dauser B; Stiftung Endometrioseforschung SEF, Westerstede, Germany.
  • Hudelist G; Freelance psychologist, Vienna, Austria.
Wien Klin Wochenschr ; 134(21-22): 772-778, 2022 Nov.
Article in En | MEDLINE | ID: mdl-36214904
ABSTRACT

BACKGROUND:

Patients suffering from colorectal deep endometriosis (DE) experience gastrointestinal symptoms with almost the same frequency as gynecological pain symptoms. Preoperatively existing gastrointestinal symptoms may translate into pathological gastrointestinal quality of life index (GIQLI) and low anterior resection syndrome scores (LARS). This prospective questionnaire-based case control study aims to assess the prevalence of gastrointestinal complaints reflected by changes in LARS and GIQLI scores in patients with colorectal deep endometriosis prior to surgical treatment and compare those to a healthy control group.

METHODS:

The study was conducted at the Hospital St. John of God in Vienna and included a total of 97 patients with histologically confirmed colorectal DE with radical surgical treatment and 96 women in whom DE was excluded via transvaginal sonography (TVS) or visually. Gastrointestinal symptoms reflected by LARS and GIQLI scores were evaluated presurgically and in controls.

RESULTS:

A total of 193 premenopausal patients were included in this study. A mean GIQLI of 90.7 ± 22.0 and 129.4 ± 11.1 was observed among patients and controls, respectively, showing a significantly higher morbidity concerning gastrointestinal symptoms and decreased quality of life (QoL) compared to healthy controls (p < 0.001). The LARS score results demonstrated that 18.6% of the patients with bowel DE presented with a major LARS and 27.8% with a minor LARS presurgically compared to 2.1% and 9.4% of control patients, respectively (p < 0.001).

CONCLUSION:

Patients with colorectal DE experience a quality of gastrointestinal symptoms translating into a decreased QoL and pathological GIQLI and LARS scores already presurgically. As a consequence, these instruments should be interpreted with caution.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Diseases / Rectal Neoplasms / Endometriosis Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: Wien Klin Wochenschr Year: 2022 Document type: Article Affiliation country: Austria

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Diseases / Rectal Neoplasms / Endometriosis Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: Wien Klin Wochenschr Year: 2022 Document type: Article Affiliation country: Austria